External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer

被引：0
|
作者：
Barth, D. A. [1 ]
Riedl, J. M. [1 ]
Foris, V. [2 ]
Posch, F. [1 ]
Mollnar, S. [1 ]
Stotz, M. [1 ]
Pichler, M. [1 ,3 ,4 ]
Stoeger, H. [1 ]
Absenger, G. [1 ]
Olschewski, H. [2 ]
Gerger, A. [1 ,5 ]
机构：
[1] Med Univ Graz, Div Clin Oncol, Dept Med, Graz, Austria
[2] Med Univ Graz, Div Pulmonol, Dept Med, Graz, Austria
[3] Med Univ Graz, Res Unit Noncoding RNAs & Genome Editing, Graz, Austria
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[5] Ctr Biomarker Res Med, Graz, Austria
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P403
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [21] Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
    Chenlu Li
    Jingjing Pan
    Jing Luo
    Xupeng Chen
    BMC Pulmonary Medicine, 21
  • [22] Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
    Li, Chenlu
    Pan, Jingjing
    Luo, Jing
    Chen, Xupeng
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [23] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [24] Lung Immune Prognostic Index (LIPI): Prognostic predictor for patients with extensive-stage small-cell lung cancer
    Majidova, Nargiz
    Seyyar, Mustafa
    Guren, Ali Kaan
    Kocaaslan, Erkam
    Kircali, Muhammed Fatih
    Sever, Nadiye
    Erel, Pinar
    Agyol, Yesim
    Pacaci, Burak
    Tunc, Mustafa Alperen
    Bayoglu, Ibrahim Vedat
    MARMARA MEDICAL JOURNAL, 2025, 38 (01): : 24 - 28
  • [25] ACTIVE IMMUNOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER
    Neninger, Elia
    Camilo Rodriguez, Pedro
    Crombet, Tania
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S194 - S194
  • [26] Personalized immunotherapy for advanced non-small cell lung cancer
    Herbst, Roy S.
    ANNALS OF ONCOLOGY, 2015, 26 : 16 - 16
  • [27] Lung immune prognostic index and survival in patients with non-small cell lung cancer: A systematic review
    Heriyanto, R. S.
    Chrystelle, C.
    Hadisurya, A.
    Tandy, F.
    Suciningtias, M.
    Kurniawan, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S809 - S810
  • [28] Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
    Carril-Ajuria, Lucia
    Lavaud, Pernelle
    Dalban, Cecile
    Negrier, Sylvie
    Gravis, Gwenaelle
    Motzer, Robert J.
    Chevreau, Christine
    Tannir, Nizar M.
    Oudard, Stephane
    McDermott, David F.
    Laguerre, Brigitte
    Hammers, Hans J.
    Barthelemy, Philippe
    Plimack, Elizabeth R.
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Jiang, Ruiyun
    Lee, Chung-Wei
    de Silva, Heshani
    Rini, Brian I.
    Escudier, Bernard
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2024, 204
  • [29] Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer
    Stokes, William A.
    Behera, Madhusmita
    Jiang, Renjian
    Gutman, David A.
    Huang, Zhonglu
    Burns, Abigail
    Sebastian, Nikhil T.
    Sukhatme, Vidula
    Lowe, Michael C.
    Ramalingam, Suresh S.
    Sukhatme, Vikas P.
    Moghanaki, Drew
    CANCER MEDICINE, 2023, 12 (01): : 358 - 367
  • [30] Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Lan
    Li, Li
    Zhou, Yingxu
    Yang, Zhaoyang
    Wang, Meng
    Gao, Yina
    Yang, Yang
    Yang, Fang
    Liu, Bao
    Hong, Xuan
    Chen, Gongyan
    JOURNAL OF CANCER, 2020, 11 (24): : 7137 - 7145
12345